2-Chloro-5-methoxyquinazoline

Catalog No.: 
ACLZUF647
CAS No.: 
1253654-39-5
Molecular Formula: 
C9H7ClN2O
Molecular Weight: 
194.62
2-Chloro-5-methoxyquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$252.00InquiryInquiry
1g97%$719.00InquiryInquiry
5g97%$3523.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-5-methoxyquinazoline
IUPAC Name2-chloro-5-methoxyquinazoline
MDL No.MFCD17215766
Molecular FormulaC9H7ClN2O
Molecular Weight194.62
SMILESCOC1=CC=CC2=NC(Cl)=NC=C12
InChI KeyYQXVLBYNMDBGAP-UHFFFAOYSA-N
Synonym2-Chloro-5-methoxy-quinazoline;Quinazoline, 2-chloro-5-methoxy-
CAS No.1253654-39-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLZUF647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACIZNQ320 route compound structure diagram
    ACIZNQ320445041-29-2In Stock
  4. Then
  5. ACLZUF647 route product structure diagram
    ACLZUF6471253654-39-5
Inquiry

2. ACLZUF647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZUF647 route product structure diagram
    ACLZUF6471253654-39-5
Inquiry

3. ACLZUF647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZUF647 route product structure diagram
    ACLZUF6471253654-39-5
Inquiry

Comments (0)